CL
MEDP icon

CIM LLC’s Medpace MEDP Stock Holding History

CIM LLC’s Portfolio MEDP Stock Details MEDP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.93M Sell
4,023
-242
-6% -$124K 0.28% 73
2025
Q4 		$2.4M Buy
4,265
+6
+0.1% +$3.41K 0.31% 57
2025
Q3 		$2.19M Sell
4,259
-6
-0.1% -$2.62K 0.29% 67
2025
Q2 		$1.34M Buy
4,265
+237
+6% +$71.2K 0.18% 90
2025
Q1 		$1.23M Buy
4,028
+7
+0.2% +$2.35K 0.18% 88
2024
Q4 		$1.34M Sell
4,021
-3,918
-49% -$1.33M 0.19% 85
2024
Q3 		$2.65M Sell
7,939
-26
-0.3% -$9.88K 0.38% 48
2024
Q2 		$2.77M Buy
7,965
+21
+0.3% +$8.32K 0.42% 45
2024
Q1 		$3.21M Sell
7,944
-2
-0% -$703 0.49% 43
2023
Q4 		$3.13M Sell
7,946
-179
-2% -$48.3K 0.49% 39
2023
Q3 		$1.97M Buy
8,125
+44
+0.5% +$11.3K 0.37% 49
2023
Q2 		$1.94M Sell
8,081
-1,316
-14% -$273K 0.36% 49
2023
Q1 		$1.77M Buy
9,397
+23
+0.2% +$4.76K 0.35% 53
2022
Q4 		$2.11M Buy
9,374
+7,054
+304% +$1.41M 0.42% 45
2022
Q3 		$516K Sell
2,320
-205
-8% -$32.7K 0.11% 103
2022
Q2 		$396K Sell
2,525
-45
-2% -$6.51K 0.08% 102
2022
Q1 		$409K Buy
2,570
+69
+3% +$11.4K 0.08% 105
2021
Q4 		$420K Buy
2,501
+178
+8% +$37.3K 0.08% 103
2021
Q3 		$525K Buy
2,323
+92
+4% +$16.8K 0.08% 103
2021
Q2 		$397K Buy
2,231
+164
+8% +$28.3K 0.06% 109
2021
Q1 		$328K Sell
2,067
-441
-18% -$67.5K 0.06% 116
2020
Q4 		$369K Sell
2,508
-52
-2% -$6.55K 0.07% 114
2020
Q3 		$308K Sell
2,560
-151
-6% -$17.5K 0.06% 115
2020
Q2 		$252K Buy
+2,711
New +$231K 0.07% 99
2020
Q1 		– Sell
-2,751
Closed -$231K – 110
2019
Q4 		$231K Sell
2,751
-10
-0.4% -$774 0.07% 98
2019
Q3 		$232K Buy
+2,761
New +$209K 0.08% 94
2018
Q4 		– Sell
-3,640
Closed -$218K – 113
2018
Q3 		$218K Buy
+3,640
New +$199K 0.08% 108

Other funds holding MEDP

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

CIM LLC's MEDP Position: Q1 2026 in Review

CIM LLC reduced its Medpace (MEDP) stake by 5.7% in Q1 2026, selling an estimated $124K and leaving 4,023 shares worth $1.93M. The position accounts for 0.28% of the portfolio, ranked #73.

CIM LLC first reported a position in MEDP in Q3 2018 and has held it in 27 quarters since. The position peaked at $3.21M in Q1 2024. 730 funds tracked by Wall St. Rank hold MEDP as of Q1 2026.

  • CIM LLC held 4,023 shares of Medpace worth $1.93M as of Q1 2026.
  • CIM LLC sold 242 Medpace shares in Q1 2026, an estimated $124K.
  • Medpace made up 0.28% of CIM LLC's portfolio in Q1 2026, its #73 holding.
  • CIM LLC first reported a position in Medpace in Q3 2018 and has held it in 27 quarters since.
  • CIM LLC's Medpace position peaked at $3.21M in Q1 2024.
  • 730 funds tracked by Wall St. Rank held Medpace as of Q1 2026.

Based on CIM LLC's 13F filing for Q1 2026, filed 18 May 2026.